Take all the complexity of running a technology company, add to it the unique and unchartered territory of advanced bioengineering, and you have unimagined potential, as well as a plethora of uncertainties.
Biotechnology companies require legal resources and talent that understand their business issues, and the implications of its technology, products and operations. The regulatory issues alone demand a high degree of specialized expertise. Sills Cummis & Gross attorneys have developed a competence that our biotechnology clients have come to rely on in a variety of circumstances.
Our work is custom tailored to each client's needs, be it start-up or public, R&D or major public pharmaceutical or medical device company. Our added value is in our experience and practical business-oriented advice. We keep you up-to-date on changes in the financing, licensing, regulatory and competitive environments.
As counsel to many biotech companies, we manage the law, allowing our clients to focus on the future.
For more information, view our Life Sciences Practice.